Sustained-release drug delivery device to manage biofilm implant-related infection

Active Project Grant Awarded Last action

Award ID
HT94252410185
Recipient
Awarding agency
Obligated
$5,468,175

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date 63% complete
Place of performance
Salt Lake City, UT 84112, USA

Award details come from USAspending.gov.

About this award

The Department of the Army Medical Command has awarded a $5,468,175 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Utah to develop a sustained-release drug delivery device to manage biofilm implant-related infections. The project, with a performance period from May 1, 2024 to April 30, 2028, will involve the University of Utah collaborating with Purgo Scientific LLC as a sub-awardee to advance this innovative medical technology. The goal is to create a drug delivery system capable of effectively treating implant-related infections, which pose significant challenges in military medicine and healthcare more broadly. This award reflects the program's emphasis on supporting high-impact biomedical research to improve health outcomes for service members, veterans, and the general public.

Subawards

Subrecipient Amount Awarded
Purgo Scientific LLC Sustained release drug delivery device to manage biofilm implant-related infection $46,085
Purgo Scientific LLC $1,513,954

Quick answers

Who received award HT94252410185?

HT94252410185 was awarded to University Of Utah by Defense Health Agency (Department of Defense) on May 1, 2024.

How much is award HT94252410185 worth?

$5,468,175 has been obligated on HT94252410185.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award